Crisaborole and apremilast: pde4 inhibitors with similar mechanism of action, different indications for management of inflammatory skin conditions

Crisaborole and apremilast: pde4 inhibitors with similar mechanism of action, different indications for management of inflammatory skin conditions

Categories: